Navigation Links
Collagen Meniscus Implant

ProductsCollagen Meniscus Implant
Company ReGen Biologics
Item Collagen Meniscus Implant
Features 
  • A type I collagen implant designed for patients with an irreparable meniscus tear or loss of meniscus tissue
  • The purpose of the CMI is to assist patients to regain mobility and return to a more vigorous lifestyle, while forestalling or minimizing degenerative joint disease.
  • Assists the body to generate new tissue, which replaces the damaged meniscus tissue removed by the surgeon.
  • The result is designed to provide patients with increased mobility and a return to a more active lifestyle.
  • Description The Collagen Meniscus Implant (CMI) is a type I collagen implant designed for patients with an irreparable meniscus tear or loss of meniscus tissue, typically through an arthroscopic partial meniscectomy procedure. The purpose of the CMI is to assist patients to regain mobility and return to a more vigorous lifestyle, while forestalling or minimizing degenerative joint disease. The Collagen Meniscus Implant is a method of regenerating meniscus tissue using the body's own healing process. A next generation approach to tissue repair, the CMI assists the body to generate new tissue, which replaces the damaged meniscus tissue removed by the surgeon. The result is designed to provide patients with increased mobility and a return to a more active lifestyle. The CMI is a resorbable type I collagen scaffold designed to minimize progressive degenerative changes in the knee after a partial meniscectomy by providing an alternative to the permanent loss of meniscus tissue. The CMI is similar to the natural shape of the meniscus and it is made of highly purified collagen, the most commonly found protein in the body. In cases where meniscus tissue cannot be repaired by suturing, the damaged tissue is removed and the CMI is sutured in place filling the defect where tissue is missing. Once sutured in place, the CMI provides a matrix into which the body's own cells may begin to move or migrate. New meniscus tissue is formed as these cells migrate and multiply. As this tissue regeneration takes place, the CMI is absorbed by the body. The regenerated tissue has the potential to restore function, reduce pain, and possibily suspend the degenerative process that begins with the loss of meniscus tissue. The CMI is made of type I collagen and it is a biocompatible, bioresorbable material that is designed to provide a scaffold for tissue growth when implanted in the knee. The surgeon sutures the CMI into the area where the meniscus tissue is missing. Once implanted, the CMI's highly porous matrix allows cellular ingrowth from the patient's own cells. This process regenerates meniscus tissue which provides the potential for restoring function, reducing pain and possibly arresting the degenerative process that begins with the loss of meniscus tissue.
    Info ReGen Biologics
    Customer Service: (201) 651-5140
    Web site: http://www.regenbio.com

    Related medicine products :

    1. Temporary Collagen Plugs
    2. Ultrafoam Collagen Sponge
    3. UltraPlug Collagen Absorbably Punctal Plugs
    4. INSTAT Collagen Absorbable Hemostat
    5. Pelvicol Acellular Collagen Matrix (Continence)
    6. Contigen Bard Collagen Implant
    7. Pelvicol® Acellular Collagen Matrix
    8. PelviSoft® Acellular Collagen BioMesh
    9. Hydrix XM Collagen Matrix
    10. Zyderm® and Zyplast® Injectable Collagen Implants
    11. CosmoDerm®and CosmoPlast® Collagen Replacement Therapy®
    Tying forceps with 6.5 mm tying platform. Round handle with flats provide flexibility of round handle with the stability of a flat handle. Straight shafts. Overall length 3.9 inches....
    Angled 45 degree shafts with 10.5 mm tying and 1 mm of tip crisscross serrated. Serrated handle with dull finish. Manufactured in titanium. Overall length 3.2 inches....
    Straight shafts with 4 mm tying platform. Serrated handle with dull finish. Manufactured in titanium. Overall length 3.3 inches....
    Angled Castroviejo handle. Manufactured in titanium. Overall length 4.2 inches....
    Medicine Products:
    (Date:6/26/2016)... (PRWEB) , ... June 26, 2016 , ... On June ... sponsor of the 2016 Cereal Festival and World’s Longest Breakfast Table in Battle Creek, ... of the city’s history as home to some of the world’s leading providers of ...
    (Date:6/25/2016)... D.C. (PRWEB) , ... June 25, 2016 , ... ... discuss health policy issues and applications at AcademyHealth’s Annual Research Meeting June 26-28, ... their work on several important health care topics including advance care planning, healthcare ...
    (Date:6/25/2016)... , ... June 25, 2016 , ... As a lifelong ... Cum Laude and his M.D from the David Geffen School of Medicine at UCLA. ... to Los Angeles to complete his fellowship in hematology/oncology at the UCLA-Olive View-Cedars Sinai ...
    (Date:6/24/2016)... ... June 24, 2016 , ... Those who have experienced traumatic events may suffer ... unhealthy avenues, such as drug or alcohol abuse, as a coping mechanism. To avoid ... healthy coping following a traumatic event. , Trauma sufferers tend to feel a range ...
    (Date:6/24/2016)... San Francisco, CA (PRWEB) , ... June 24, ... ... at CitiDent, is now offering micro-osteoperforation for accelerated orthodontic treatment. Dr. Cheng has ... , self-ligating Damon brackets , AcceleDent, and accelerated osteogenic orthodontics. , ...
    Breaking Medicine News(10 mins):
    (Date:6/23/2016)... , June 23, 2016 Research ... Devices Global Market - Forecast to 2022" report to ... the treatment method for the patients with kidney failure, it ... excess fluid from the patient,s blood and thus the treatment ... potassium and chloride in balance. Increasing number ...
    (Date:6/23/2016)... Roche (SIX: RO, ROG; OTCQX: RHHBY) announced ... BRAHMS PCT (procalcitonin) assay as a dedicated testing solution ... this clearance, Roche is the first IVD company in ... sepsis risk assessment and management. PCT is ... levels in blood can aid clinicians in assessing the ...
    (Date:6/23/2016)... , June 23, 2016 Bracket , a ... its next generation clinical outcomes platform, Bracket eCOA (SM) ... on June 26 – 30, 2016 in Philadelphia ... electronic Clinical Outcome Assessment product of its kind to fully ... Bracket eCOA 6.0 is a flexible platform for ...
    Breaking Medicine Technology: